Insiders Harrow, Inc.

Equities

Real-time Estimate Cboe BZX Other stock markets 01:16:38 27/06/2024 am IST			5-day change	1st Jan Change
21.32 ^USD	-1.46%		+7.07%	+90.54%

24/06	Harrow, Inc.(NasdaqGM:HROW) added to S&P Pharmaceuticals Select Industry Index	CI
21/06	Craig-Hallum Adjusts Price Target on Harrow Health to $30 From $26, Buy Rating Maintained	MT

Harrow Names Greg Dipasquale as Senior Vice President, Head of Commercial	13/05	CI
Harrow, Inc. Announces Board of Director Appointments	29/01	CI
Harrow, Inc. Appoints John P. Saharek as President and Chief Executive Officer of its ImprimisRx Division	03/01	CI
Harrow, Inc. Announces Board and Committee Changes	04/11	CI
Insider Buy: Harrow Health	15/23/15	MT
Harrow Health, Inc. Announces Appointment of Mark Mannebach as Head of Regulatory Affairs and Pharmacovigilance	06/23/06	CI
Insider Buy: Harrow Health	23/22/23	MT
Insider Buy: Harrow Health	23/22/23	MT
Insider Sell: Harrow Health	04/22/04	MT
Akari Therapeutics Names Melissa Bradford-Klug COO	13/22/13	MT
Harrow Health, Inc. Announces Management Changes	31/22/31	CI
Harrow Health, Inc Announces Board Changes	24/21/24	CI
Insider Trends: Insider Purchase of Harrow Health Stock Continues 90-Day Positive Trend	20/21/20	MT
Insider Trends: Insider Purchase of Harrow Health Stock Extends 90-Day Positive Trend	22/21/22	MT
Insider Trends: Insider Purchase of Harrow Health Stock Extends 90-Day Positive Trend	22/21/22	MT
Insider Trends: Insider Disposition Eases Back 90-Day Buy Trend at Harrow Health	22/21/22	MT
Insider Trends: Harrow Health Insider 90-Day Buying Trend Prolonged with Purchase	23/20/23	MT
Harrow Health Appoints Larry Van Horn to its Board of Directors	30/20/30	CI
Harrow Health, Inc. Announces Board and Committee Changes	17/20/17	CI
Harrow Health, Inc. Announces Launch of Mayfield Pharmaceuticals; to Appoint Melissa Bradford-Klug to Lead Mayfield Pharmaceuticals, Inc	31/19/31	CI

No results for this search